期刊文献+

川崎病并发心肌梗死5例报告 被引量:8

Kawasaki disease combined with myocardial infarction: five case reports and literature review
暂未订购
导出
摘要 目的:报告5例川崎病并发心肌梗死患儿资料,以提高对该病的认识和临床诊治水平。方法:分析该院5例川崎病并发心肌梗死患儿的临床表现、辅助检查(心肌酶谱、心电图、UCG)、治疗及预后。结果:4例患儿发生心肌梗死时表现为烦躁不安,面色苍白等,1例患儿无任何临床表现。5例均有CK-MB升高、CTnI阳性,心电图出现病理性Q波,ST-T段改变。UCG可见节段性室壁运动异常,其中2例合并冠状动脉瘤形成,2例冠状动脉扩张,另1例未发现冠状动脉病变。其中3例给予尿激酶溶栓治疗,5例均同时予抗血小板、抗凝治疗后抢救成功。对5例患儿均长期、规范随诊,至撰稿日未再出现心肌梗死,预后良好。结论:心肌梗死是川崎病主要死亡原因之一,发病时隐匿但凶险,可根据典型心电图、心肌酶谱及UCG明确诊断,治疗需给予及时溶栓,后期规范随诊,以防心肌梗死再发。 Objectives: To describe the clinical features of 5 children diagnosed as Kawasaki disease (KD) complicated with myocardial infarction. Methods: Five children suffered from KD complicated with myocardial in- farction were included. Clinical features, laboratory data [ serum myocardial enzymes, electrocardiogram (ECG) and echocardiography ], treatment and prognosis were retrospectively studied and related literatures were reviewed. Results: Four cases presented as irritable and pale, one as asymptomatic. All cases had elevated levels of CK- MB, positive CTnI, abnormal deep Q waves, change of ST segment and T waves. Abnormalities of the left ventric- ular regional wall motion were detected by echocardiography. Two cases had coronary aneurysms, two with dilated coronary, one with normal coronary artery. Three children received thrombolytic therapy with urokinase. All cases were treated with anti-platelet and anticoagulation. Myocardial infarction does not recur in the long-term follow-up, with very good outcome. Conclusion: The clinical manifestations are not representative in KD with myocardial in- farction. Prompt diagnosis could be attained according to the change of serum myocardial enzymes, ECG and echo- cardiography. Thrombolytic therapy should provide immediately. And long-term follow up is required for preventing myocardial infarction recurrence.
出处 《新医学》 2013年第4期243-246,共4页 Journal of New Medicine
关键词 川崎病 心肌梗死 冠状动脉病变 Kawasaki disease Myocardial infarction Coronary artery lesions
  • 相关文献

参考文献15

  • 1姜毅,李温慈,徐海滨,邵山鹰.川崎病患儿血清胱抑素C的变化及其与冠状动脉病变的关系[J].新医学,2011,42(10):638-639. 被引量:6
  • 2Tsuda E, Hirata T, Matsuo O, et al. The 30-year out- come for patients after myocardial infarction due to coro- nary artery lesions caused by Kawasaki disease. Pediatr Cardiol, 2011, 32: 176-182.
  • 3Newburger JW, Takahashi M, Gerber MA, et al. Diag- nosis, treatment, and long-term management of Kawasa- ki disease: a statement for health professionals from the committee on rheumatic fever, endocarditis, and Ka- wasaki disease, council on cardiovascular disease in theyoung, American Heart Association. Pediatrics, 2004, 114: 1708-1733.
  • 4Nakamura Y, Yanagawa H, Harada K, et al. Mortality among persons with a history of Kawasaki disease in Ja- pan: The fifth look. Arch Pediatr Adolese Med, 2002, 156: 162-165.
  • 5Kato H, Ichinose E, Kawasaki T. Myocardial infarction in Kawasaki disease: clinical analyses in 195 case. J Pediatr, 1986, 108: 923-927.
  • 6Nakano H, Saito A, Ueda K, et al. Clinical characteris- tics of myocardial infarction following Kawasaki disease: Report of 11 eases. J Pediatr, 1986 ; 108 : 198-203.
  • 7Samada K, Shiraishi H, Sato A, et al. Grown-up Ka- wasaki disease patients who have giant coronary aneu- rysms. World J Pediatr, 2010, 6: 38-42.
  • 8Subramanian S, Gaum WE. Acute myocardial infarction caused by transient coronary vasospasm in a child with Kawasaki disease and no coronary aneurysms. Pediatr Cardiol, 2010, 31: 875-877.
  • 9Liu S, Wang H, Wang XY, et al. Diagnostic signifi- cance of creatine kinase mass in children with myocardi- al injury. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, 2011, 23 : 363-364.
  • 10Jasra SK, Badian C, Macri I, et al. Recognition of ear- ly myocardial infarction by immunohistochemical stainingwith cardiac troponin-I and complement C9. J Forensic Sci, 2012, 57: 1595-1600.

二级参考文献9

  • 1田青,吴日勉,包忠宪,肖钢明,乐新.川崎病的早期诊断探讨——附72例分析[J].新医学,2004,35(10):615-616. 被引量:5
  • 2郑伏甫,郑克立,王长希,陈立中,戴宇平,费继光.血清胱抑素C判断移植肾功能的研究[J].新医学,2005,36(4):199-201. 被引量:13
  • 3LUTGENS S P, CLEUTJENS K B, DAEMEN M J, et al. Cathepsin cysteine proteases in cardiovas-cular disease [J]. FASEB J, 2007, 21 (12) : 3029-3041.
  • 4FUKAZAWA R. Long-term prognosis of Kawasaki dis- ease: increased cardiovascular risk? [ J]. Curr Opin Pe- diatr, 2010, 22 (5): 587-592.
  • 5KOROLENKO T A, FILATOVA T G, CHERKANOVA M S, et al. Cystatins: cysteine proteases regulation and dis- turbances in tumors and inflammation [ J ]. Biomed Khim,2008, 54 (2): 210-217.
  • 6VINCENTS B, VINDEBRO R, ABRAHAMSON M, et al. The human protease inhibitor cystatin C is an activa- ting cofactor for the streptococcal cysteine protease Ides[J]. Chem Biol, 2008, 15 (9) : 960-968.
  • 7YETKIN E, WALTENBERGER J. Cathepsin enzymes and cystatin C: do they play a role in positive arterial re- modeling? [J]. Stroke, 2009, 40 (2): e26-e27.
  • 8杨锡强,易著文.儿科学[M].6版.北京:人民卫生出版社,2006.309-314.
  • 9孙世荣,董强.肾病综合征患者血清胱抑素C检测的临床意义[J].中国老年学杂志,2009,29(14):1830-1831. 被引量:16

共引文献5

同被引文献102

引证文献8

二级引证文献52

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部